HEALTH

UpLift Nutrition signs sponsor, advertising agreement for mixed martial arts event

BY Michael Johnsen

ROY, Utah UpLift Nutrition on Monday signed a sponsor/advertising agreement with Throwdown Elite and Showdown Productions, a leader in ‘alternative fitness’ and mixed martial arts, to promote the company’s All-Day Energy spray.

As a sponsor of Throwdown Elite, UpLift will be advertising to MMA enthusiasts viewing the fights via television (Comcast on Demand and other local/national coverage), visiting Throwdown’s Web site or listening to the tri-weekly radio show (The Cage News, 1280 am, The Zone).

UpLift also will have prominent placement at the live Utah MMA fighting event on Sept. 26, the company added.

All-Day Energy spray is an energy-enhancing mouth spray for people on the go, and is available in four flavors – mint, grape, citrus and cinnamon.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

WHO director-general: H1N1 outcome in Southern Hemisphere positive

BY Michael Johnsen

CANCUN, Mexico Delivering the keynote speech at a high-level meeting on influenza H1N1 on Thursday, Margaret Chan, director-general of the World Health Organization, suggested that early reports out of the Southern Hemisphere around the severity of the H1N1 pandemic are positive.

“We are still seeing a largely reassuring clinical picture,” she said. “The overwhelming majority of patients experience mild symptoms and make a full recovery within a week, often in the absence of any form of medical treatment. Research published last week confirms that this pattern, in which most patients experience mild influenza-like illness, has also been seen in Mexico.”

Most cases of severe and fatal infection continue to occur in people with underlying medical conditions. Pregnant women are also at increased risk of complications, she said. “But there are some exceptions that must be the focus of particular concern,” she added. “For reasons that are poorly understood, some deaths are occurring in perfectly healthy young people. Moreover, some patients experience a very rapid clinical deterioration, leading to severe, life-threatening viral pneumonia that requires mechanical ventilation.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Acid-reducing medicines may lead to dependency

BY Anna Mcgrath

NEW YORK Treatment with proton-pump inhibitors could have the opposite of the intended effect in healthy people, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

Researchers studied the effects of PPIs for eight weeks, finding that instead of reducing such acid-related symptoms as heartburn, acid regurgitation and dyspepsia post-treatment, the symptoms returned once the therapy ended.

“This study indicates unrecognized aspects of PPI withdrawal and is a very strong indication of a clinically significant acid rebound phenomenon that needs to be investigated in proper patient populations,” said Christina Reimer, MD, of Copenhagen University and lead author of the study.

According to earlier studies, 33% of patients who initiate PPI treatment continue to refill their prescriptions without an obvious indication for maintenance therapy. Rebound acid hypersecretion, defined as an increase in gastric acid secretion above pre-treatment levels following antisecretory therapy, is observed within two weeks after withdrawal of treatment and could theoretically lead to such acid-related symptoms as heartburn, acid regurgitation or dyspepsia that might result in resumption of therapy.

Data showed 44% of those randomized to PPIs reported at least one relevant acid-related symptom compared to 15% in the placebo group.

“We find it highly likely that the symptoms observed in this trial are caused by rebound acid hypersecretion and that this phenomenon is equally relevant in patients treated long term with PPIs. If rebound acid hypersecretion induces acid-related symptoms, this might lead to PPI dependency. Our results justify the speculation that PPI dependency could be one of the explanations for the rapidly and continuously increasing use of PPIs,” said Reimer.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?